Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New agents for H. pylori-related disorders patented by Takeda

Dec. 14, 2000

Taisho discovers new histamine H2 antagonist with antisecretory activity

Dec. 13, 2000

FDA approves new indications for Prevacid

Dec. 12, 2000

Phase I trial of new treatment for HCV and associated liver cancer cleared in Israel

Dec. 4, 2000

Nitric oxide synthase inhibitors for inflammation and pain described by AstraZeneca

Nov. 30, 2000

Secondary efficacy measures improved by ISIS-2302 treatment in Crohn's disease

Nov. 30, 2000

New target for IBD treatment discussed at UEGW: leukocyte-platelet aggregation

Nov. 30, 2000

Mechanism of action of thalidomide in Crohn's disease investigated as part of clinical trial

Nov. 30, 2000

Immediate withdrawal of Lotronex in U.S. announced by Glaxo Wellcome

Nov. 29, 2000

Synthetic immunomodulatory peptide inhibits production of proinflammatory cytokines in CD

Nov. 29, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...